Dr. Hamid R. Mirshahidi
Claim this profileLoma Linda University Medical Center
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
10 reported clinical trials
18 drugs studied
Area of expertise
1Lung Cancer
Stage II
Stage I
Stage III
2Non-Small Cell Lung Cancer
Stage II
Stage I
Stage III
Affiliated Hospitals
Clinical Trials Hamid R. Mirshahidi is currently running
APL-101
for Lung Cancer
This trial is testing APL-101, a new drug, on patients with specific genetic changes in their cancer. These patients often don't respond to typical treatments. The drug aims to block a protein that helps cancer cells grow and spread.
Recruiting1 award Phase 211 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about Hamid R. Mirshahidi
Clinical Trial Related6 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Hamid R. Mirshahidi has experience with
- Pembrolizumab
- Atezolizumab
- Carboplatin
- Pemetrexed Disodium
- Gemcitabine Hydrochloride
- Ramucirumab
Breakdown of trials Hamid R. Mirshahidi has run
Lung Cancer
Non-Small Cell Lung Cancer
Pancreatic Cancer
Brain Tumor
Colon Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Hamid R. Mirshahidi specialize in?
Hamid R. Mirshahidi focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage II patients, or patients who are Stage I.
Is Hamid R. Mirshahidi currently recruiting for clinical trials?
Yes, Hamid R. Mirshahidi is currently recruiting for 4 clinical trials in Loma Linda California. If you're interested in participating, you should apply.
Are there any treatments that Hamid R. Mirshahidi has studied deeply?
Yes, Hamid R. Mirshahidi has studied treatments such as Pembrolizumab, Atezolizumab, Carboplatin.
What is the best way to schedule an appointment with Hamid R. Mirshahidi?
Apply for one of the trials that Hamid R. Mirshahidi is conducting.
What is the office address of Hamid R. Mirshahidi?
The office of Hamid R. Mirshahidi is located at: Loma Linda University Medical Center, Loma Linda, California 92354 United States. This is the address for their practice at the Loma Linda University Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.